Metraipolis › archive › dc_9ff25901d94e

Efficient Response-Adaptive Randomization for Multi-arm Trials with Prioritized Composite Endpoints — arXiv:2608.11953

Source
arXiv (en)
Original
https://arxiv.org/abs/2608.11953
License (as archived)
CC0-1.0
Archived
2026-10-19T05:43:17.007Z
SHA-256 of the archived text
4adcda1576e80e7afaec41a412264e6c47ad4d66c33abfcefcf5cbb7a7d1ccac
Stable URL of this page
https://metraipolis.com/documento/dc_9ff25901d94e

How to cite

Efficient Response-Adaptive Randomization for Multi-arm Trials with Prioritized Composite Endpoints — arXiv:2608.11953 — arXiv (en), https://arxiv.org/abs/2608.11953 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_9ff25901d94e (Metraipolis archive dc_9ff25901d94e, sha256 4adcda1576e80e7afaec41a412264e6c47ad4d66c33abfcefcf5cbb7a7d1ccac)
BibTeX
@misc{dc9ff25901d94e,
  title = {Efficient Response-Adaptive Randomization for Multi-arm Trials with Prioritized Composite Endpoints — arXiv:2608.11953},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2608.11953},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_9ff25901d94e; sha256 4adcda1576e80e7afaec41a412264e6c47ad4d66c33abfcefcf5cbb7a7d1ccac},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.11953. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The efficient randomized-adaptive design attains the minimal possible variance of the allocation proportion for any pre-specified target and has been extended from two to several treatment arms, but both versions target a single response. Confirmatory trials increasingly rely on several prioritized endpoints, typically efficacy followed by safety, that cannot be reduced to one summary without losing information. The efficient randomized-adaptive design is extended here to targets driven by the net treatment benefit of generalized pairwise comparisons, allowing any number of arms and endpoints of mixed type, including censored time-to-event outcomes. Strong consistency, a law of the iterated logarithm, and asymptotic normality of the allocation proportions are established by combining a sequential Hájek projection for the net benefit with the martingale technique used for the original design, and the design is shown to attain the semiparametric efficiency bound within the class of designs that track a smooth function of the net benefit. In simulations calibrated to a three-arm phase III melanoma trial, the proposed design concentrates allocation on the superior treatment more efficiently than designs driven by a single endpoint, while preserving type I error and power. A redesign of the trial illustrates the practical benefit, and the approach is discussed in relation to current regulatory thinking on adaptive designs for confirmatory trials.

Tema degli esploratori: statistica e scienza dei dati (retro-catalogo arXiv: annunci del 2026-08-13 in stat.ME).
Categorie arXiv: Methodology (stat.ME) ; Statistics Theory (math.ST).
Pagina del lavoro: https://arxiv.org/abs/2608.11953 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-19T05:32:03.750Z dalla pagina https://arxiv.org/catchup/stat.ME/2026-08-13?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).